LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Smoke & Vape Shops for Sale
Cleaning & Janitorial Businesses for Sale
Beauty & Personal Care Businesses for Sale
Hotels and Motels for Sale
Dollar Stores for Sale
Clothing & Shoe Stores for Sale
Wholesale & Distribution Businesses for Sale
Post Office Businesses for Sale
Grocery Stores & Delis for Sale
Manufacturing Businesses for Sale
Smoke & Vape Shop Franchises for Sale
Consultancy & Training Franchise Opportunities
Service Franchises for Sale
Senior Care Franchise for Sale
Real Estate & Property Management Franchise for Sale
Convenience Store & Lotto Franchises for Sale
Laundromat & Dry Cleaning Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Gas Station & Car Wash Franchises for Sale
Vending & Kiosk Franchises for Sale
Places of Worship for Sale
Medical Office Spaces for Sale or Rent
Office Buildings for Sale or Rent
Houses & Condos for Sale or Lease
Miscellaneous Properties for Sale or Lease
Commercial Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Retail Buildings for Sale or Lease
Office Spaces for Sale or Rent
Mixed Use Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: